Increased ratio of calcineurin immunoreactive neurons in the caudate nucleus of patients with schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 37, Issue 1, 2012, Pages 8-14

  Wada, Akira ^a   Kunii, Yasuto ^a   Ikemoto, Keiko ^a   Yang, Qiaohui ^a   Hino, Mizuki ^a   Matsumoto, Junya ^a   Niwa, Shin ichi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Calcineurin; Caudate nucleus; Immunohistochemistry; Postmortem brain; Schizophrenia

Indexed keywords

BROMPERIDOL; CALCINEURIN; HALOPERIDOL; RISPERIDONE; THIORIDAZINE; ZOTEPINE;

ADULT; AGED; ARTICLE; BRAIN NERVE CELL; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PREFRONTAL CORTEX; PUTAMEN; SCHIZOPHRENIA;

ADULT; AGED; AGED, 80 AND OVER; CALCINEURIN; CAUDATE NUCLEUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURONS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84857793204     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.01.005     Document Type: Article

References (43)

1. Aparicio-Legarza M.I., Davis B., Hutson P.H., Reynolds G.P. Increased density of glutamate/N-methyl-d-aspartate receptors in putamen from schizophrenic patients. Neurosci Lett 1998, 241:143-146.
2. Arnold S.E., Trojanowski J.Q. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol 1996, 92:217-231.
3. Carlsson A. The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol Rev 1959, 11:490-493.
4. Carlsson A. Antipsychotic drugs, neurotransmitters, and schizophrenia. Am J Psychiatry 1978, 135:165-173.
5. Carlsson A. The dopamine theory revisited. Schizophrenia 1995, 379-400. Blackwell Science, Oxford. S.R. Hirsch, D.R. Weinberger (Eds.).
6. Carter C.S., Perlstein W., Ganguli R., Brar J., Mintun M., Cohen J.D. Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry 1998, 155:1285-1287.
7. Dracheva S., Marras S.A., Elhakem S.L., Kramer F.R., Davis K.L., Haroutunian V. N-methyl-d-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am J Psychiatry 2001, 158:1400-1410.
8. Eastwood S.L., Burnet P.W., Harrison P.J. Decreased hippocampal expression of the susceptibility gene PPP3CC and other calcineurin subunits in schizophrenia. Biol Psychiatry 2005, 57:702-710.
9. Gerber D.J., Hall D., Miyakawa T., Demars S., Gogos J.A., Karayiorgou M., et al. Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding calcineurin gamma subunit. Proc Natl Acad Sci U S A 2003, 100:8993-8998.
10. Goto S., Matsukado Y., Mihara Y., Inoue N., Miyamoto E. The distribution of calcineurin in rat brain by light and electron microscopic immunohistochemistry and enzyme-immunoassay. Brain Res 1986, 397:161-172.
11. Greengard P., Allen P.B., Nairn A.C. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 1999, 23:435-447.
12. Guerini D. Calcineurin: not just a simple protein phosphatase. Biochem Biophys Res Commun 1997, 235:271-275.
13. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., et al. Genome-wide expression analysis reveals dysregulation of myelination related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 2001, 98:4746-4751.
14. Heckers S., Rauch S.L., Goff D., Savage C.R., Schacter D.L., Fischman A.J., et al. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat Neurosci 1998, 1:318-323.
15. Hill C., Keks N., Roberts S., Dean B., Mackinnon A., Copolov D. Diagnostic instrument for brain studies-revised 2005, Mental Health Research Institute, Victoria, Australia.
16. Hirvonen J., van Erp T.G., Huttunen J., Aalto S., Någren K., Huttunen M., et al. Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Arch Gen Psychiatry 2005, 62:371-378.
17. Horiuchi Y., Ishiguro H., Koga M., Inada T., Iwata N., Ozaki N., et al. Support for association of the PPP3CC gene with schizophrenia. Mol Psychiatry 2007, 12:891-893.
18. Ito M., Depaz I., Wilce P., Suzuki T., Niwa S., Matsumoto I. Expression of human neuronal protein 22, a novel cytoskeleton-associated protein, was decreased in the anterior cingulate cortex of schizophrenia. Neurosci Lett 2005, 378:125-130.
19. Iwazaki T., Shibata I., Niwa S., Matsumoto I. Selective reduction of chromogranin A-like immunoreactivities in the prefrontal cortex of schizophrenic subjects: a postmortem study. Neurosci Lett 2004, 367:293-297.
20. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991, 148:1301-1308.
21. Kinoshita Y., Suzuki T., Ikeda M., Kitajima T., Yamanouchi Y., Inada T., et al. No association with the calcineurin A gamma subunit gene (PPP3CC) haplotype to Japanese schizophrenia. J Neural Transm 2005, 112:1255-1262.
22. Kozlovsky N., Scarr E., Dean B., Agam G. Postmortem brain calcineurin protein levels in schizophrenia patients are not different from controls. Schizophr Res 2006, 83:173-177.
23. Kunii Y., Yabe H., Wada A., Yang Q., Nishiura K., Niwa S. Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35(4):1139-1143.
24. Kunii Y., Ikemoto K., Wada A., Yang Q., Kusakabe T., Suzuki T., Niwa S. Detailed DARPP-32 expression profiles in post-mortem brains from patients with schizophrenia: an immunohistochemical study. Med Mol Morphol 2011, 44(4):190-199.
25. Laruelle M. Imaging dopamine transmission in schizophrenia. A review and meta-analysis. Q J Nucl Med 1998, 42:211-221.
26. Liu J.P., Sim A.T., Robinson P.J. Calcineurin inhibition of dynamin I GTPase activity coupled to nerve terminal depolarization. Science 1994, 265:970-973.
27. Malenka R.C. Synaptic plasticity in the hippocampus: LTP and LTD. Cell 1994, 78:535-538.
28. Meador-Woodruff J.H., Healy D.J. Glutamate receptor expression in schizophrenic brain. Brain Res Brain Res Rev 2000, 31:288-294.
29. Meyer-Lindenberg A.S., Olsen R.K., Kohn P.D., Brown T., Egan M.F., Weinberger D.R., et al. Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Arch Gen Psychiatry 2005, 62:379-386.
30. Miyakawa T., Leiter L.M., Gerber D.J., Gainetdinov R.R., Sotnikova T.D., Zeng H., et al. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci U S A 2003, 100:8987-8992.
31. Nishi A., Snyder G.L., Greengard P. Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J Neurosci 1997, 17:8147-8155.
32. Rajkowska G., Goldman-Rakic P.S. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria. Cereb Cortex 1995, 5:307-322.
33. Rajkowska G., Goldman-Rakic P.S. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System. Cereb Cortex 1995, 5:323-337.
34. Rusnak F., Mertz P. Calcineurin: form and function. Physiol Rev 2000, 80:1483-1521.
35. Sanders A.R., Duan J., Levinson D.F., Shi J., He D., Hou C., et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 2008, 165:497-506.
36. Schmitt A., Koschel J., Zink M., Bauer M., Sommer C., Frank J., et al. Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2010, 260:101-111.
37. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 1995, 52:805-818.
38. Simpson M.D., Slater P., Deakin J.F., Gottfries C.G., Karlsson I., Grenfeldt B., et al. Absence of basal ganglia amino acid neuron deficits in schizophrenia in three collections of brains. Schizophr Res 1998, 31:167-175.
39. Solà C., Tusell J.M., Serratosa J. Comparative study of the distribution of calmodulin kinaseII and calcineurin in the mouse brain. J Neurosci Res 1999, 57:651-662.
40. Suzuki K., Sato M., Morishima Y., Nakanishi S. Neuronal depolarization controls brain-derived neurotrophic factor-induced upregulation of NR2C NMDA receptor via calcineurin signaling. J Neurosci 2005, 25:9535-9543.
41. Wong D.F., Wagner H.N., Tune L.E., Dannals R.F., Pearlson G.D., Links J.M., et al. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 1986, 234:1558-1563.
42. Xi Z., Yu L., Shi Y., Zhang J., Zheng Y., He G., et al. No association between PPP3CC and schizophrenia in the Chinese population. Schizophr Res 2007, 90:357-359.
43. Zeng H., Chattarji S., Barbarosie M., Rondi-Reig L., Philpot B.D., Miyakawa T., et al. Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 2001, 107:617-629.